Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutriflex Omega special is a parenteral nutrition solution developed by B. Braun, designed for intravenous administration in patients requiring nutritional support when oral or enteral nutrition is impossible, insufficient, or contraindicated. It is a three-chamber bag system containing amino acids, glucose, electrolytes, and a lipid emulsion enriched with omega-3 fatty acids (fish oil). The inclusion of omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), is intended to modulate the inflammatory response and improve clinical outcomes in critically ill or surgical patients. The special designation typically indicates a formulation with a high concentration of amino acids and energy, suitable for patients with high metabolic requirements and is intended for central venous administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nutriflex Omega special.